Csaba J. Peto, Ph.D. is a synthetic medicinal chemist. His primary research focus is the discovery and development of small molecule drug candidates for cancer therapy. Utilitzing his two decades of experience in the biotech industry, Dr. Peto designs and synthesizes compounds for multi-parametric optimization that target oncogenic signaling pathways.